SM
NVAX icon

Sabby Management’s Novavax NVAX Stock Holding History

Sabby Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-430
Closed -$474K – 104
2019
Q1 		$474K Buy
+430
New +$13.6K 0.23% 32
2016
Q4 		– Sell
-42
Closed -$176K – 319
2016
Q3 		$176K Sell
42
-480
-92% -$62K 0.01% 275
2016
Q2 		$7.59M Buy
522
+478
+1,086% +$54.8K 0.4% 44
2016
Q1 		$454K Sell
44
-10
-19% -$1.07K 0.02% 217
2015
Q4 		$906K Sell
54
-367
-87% -$56.5K 0.05% 196
2015
Q3 		$5.95M Buy
421
+76
+22% +$17K 0.25% 67
2015
Q2 		$7.68M Buy
345
+34
+11% +$5.98K 0.28% 71
2015
Q1 		$5.15M Buy
+311
New +$50.5K 0.21% 74
2014
Q3 		– Sell
-272
Closed -$2.52M – 279
2014
Q2 		$2.52M Sell
272
-125
-31% -$11K 0.11% 90
2014
Q1 		$3.6M Buy
397
+301
+314% +$33.6K 0.2% 76
2013
Q4 		$984K Buy
+96
New +$6.78K 0.06% 118

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sabby Management's NVAX Position: Q2 2019 in Review

Sabby Management sold out of Novavax (NVAX) in Q2 2019, closing a stake of 43,000 shares — an estimated $474K sold.

Sabby Management first reported a position in NVAX in Q3 2013 and held it in 7 quarters. The position peaked at $3.73M in Q3 2015. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • Sabby Management reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • Sabby Management sold 43,000 Novavax shares in Q2 2019, an estimated $474K.
  • Sabby Management first reported a position in Novavax in Q3 2013 and held it in 7 quarters.
  • Sabby Management's Novavax position peaked at $3.73M in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.